Patents Assigned to Vectus Biosystems Limited
  • Compositions for the treatment of hypertension and/or fibrosis
    Patent number: 11834417
    Abstract: The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of hypertension and/or fibrosis.
    Type: Grant
    Filed: May 10, 2021
    Date of Patent: December 5, 2023
    Assignee: VECTUS BIOSYSTEMS LIMITED
    Inventor: Karen Annette Duggan
  • Compositions for the treatment of pulmonary fibrosis
    Patent number: 11401245
    Abstract: The present invention relates to compounds and their use in the prophylactic and/or therapeutic treatment of pulmonary fibrosis and/or related conditions.
    Type: Grant
    Filed: January 6, 2021
    Date of Patent: August 2, 2022
    Assignee: VECTUS BIOSYSTEMS LIMITED
    Inventor: Karen Annette Duggan
  • Synthesis of terphenyl compounds
    Patent number: 11401235
    Abstract: The present invention relates novel methods of synthesizing terphenyl compounds and in particular to novel methods for the synthesis of a compound of Formula I or intermediates thereof.
    Type: Grant
    Filed: July 1, 2020
    Date of Patent: August 2, 2022
    Assignee: VECTUS BIOSYSTEMS LIMITED
    Inventors: Anthony Kaye, Nurul Quazi, George Feast, Marshnil Lakshman
  • Compositions for the Treatment of Hypertension and/or Fibrosis
    Publication number: 20210284612
    Abstract: The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of hypertension and/or fibrosis.
    Type: Application
    Filed: May 10, 2021
    Publication date: September 16, 2021
    Applicant: Vectus Biosystems Limited
    Inventor: Karen Annette DUGGAN
  • Compositions for the treatment of hypertension and/or fibrosis
    Patent number: 11053202
    Abstract: The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of hypertension and/or fibrosis.
    Type: Grant
    Filed: September 21, 2017
    Date of Patent: July 6, 2021
    Assignee: Vectus Biosystems Limited
    Inventor: Karen Annette Duggan
  • COMPOSITIONS FOR THE TREATMENT OF PULMONARY FIBROSIS
    Publication number: 20210130301
    Abstract: The present invention relates to compounds and their use in the prophylactic and/or therapeutic treatment of pulmonary fibrosis and/or related conditions.
    Type: Application
    Filed: January 6, 2021
    Publication date: May 6, 2021
    Applicant: Vectus Biosystems Limited
    Inventor: Karen Annette DUGGAN
  • Compositions for the treatment of pulmonary fibrosis
    Patent number: 10919863
    Abstract: The present invention relates to compounds and their use in the prophylactic and/or therapeutic treatment of pulmonary fibrosis and/or related conditions.
    Type: Grant
    Filed: July 28, 2017
    Date of Patent: February 16, 2021
    Assignee: Vectus Biosystems Limited
    Inventor: Karen Annette Duggan
  • Synthesis of terphenyl compounds
    Patent number: 10752578
    Abstract: The present invention relates novel methods of synthesizing terphenyl compounds and in particular to novel methods for the synthesis of a compound of Formula I or intermediates thereof.
    Type: Grant
    Filed: September 21, 2016
    Date of Patent: August 25, 2020
    Assignee: Vectus Biosystems Limited
    Inventors: Anthony Kaye, Nurul Quazi, George Feast, Marshnil Lakshman
  • COMPOSITIONS FOR THE TREATMENT OF PULMONARY FIBROSIS
    Publication number: 20190270712
    Abstract: The present invention relates to compounds and their use in the prophylactic and/or therapeutic treatment of pulmonary fibrosis and/or related conditions.
    Type: Application
    Filed: July 28, 2017
    Publication date: September 5, 2019
    Applicant: Vectus Biosystems Limited
    Inventor: Karen Annette DUGGAN
  • Compositions for the treatment of kidney and/or liver disease
    Patent number: 10183908
    Abstract: The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of kidney and/or liver disease.
    Type: Grant
    Filed: March 18, 2016
    Date of Patent: January 22, 2019
    Assignee: VECTUS BIOSYSTEMS LIMITED
    Inventor: Karen Annette Duggan
  • Compositions for the treatment of fibrosis and fibrosis-related conditions
    Patent number: 10035775
    Abstract: The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of fibrosis and fibrosis-related conditions.
    Type: Grant
    Filed: March 18, 2016
    Date of Patent: July 31, 2018
    Assignee: VECTUS BIOSYSTEMS LIMITED
    Inventor: Karen Annette Duggan
  • COMPOSITIONS FOR THE TREATMENT OF FIBROSIS AND FIBROSIS-RELATED CONDITIONS
    Publication number: 20180072682
    Abstract: The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of fibrosis and fibrosis-related conditions.
    Type: Application
    Filed: March 18, 2016
    Publication date: March 15, 2018
    Applicant: VECTUS BIOSYSTEMS LIMITED
    Inventor: KAREN ANNETTE DUGGAN
  • COMPOSITIONS FOR THE TREATMENT OF KIDNEY AND/OR LIVER DISEASE
    Publication number: 20180037539
    Abstract: The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of kidney and/or liver disease.
    Type: Application
    Filed: March 18, 2016
    Publication date: February 8, 2018
    Applicant: VECTUS BIOSYSTEMS LIMITED
    Inventor: Karen Annette DUGGAN
  • VIP fragments and methods of use
    Patent number: 9732136
    Abstract: The invention relates to composition comprising a pharmaceutically effective amount of one or more functional vasoactive intestinal peptide (VIP) fragments, and the use of those compositions in the treatment of fibrosis, hypertension and other disorders.
    Type: Grant
    Filed: April 19, 2016
    Date of Patent: August 15, 2017
    Assignee: VECTUS BIOSYSTEMS LIMITED
    Inventor: Karen Annette Duggan
  • Compositions for the treatment of hypertension and/or fibrosis
    Patent number: 9630935
    Abstract: The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of hypertension and/or fibrosis.
    Type: Grant
    Filed: September 17, 2014
    Date of Patent: April 25, 2017
    Assignee: VECTUS BIOSYSTEMS LIMITED
    Inventor: Karen Annette Duggan
  • Compositions for the treatment of hypertension and/or fibrosis
    Patent number: 9458093
    Abstract: The present invention relates to a novel terphenyl compound and its use in the prophylactic and/or therapeutic treatment of hypertension and/or fibrosis.
    Type: Grant
    Filed: September 17, 2014
    Date of Patent: October 4, 2016
    Assignee: Vectus Biosystems Limited
    Inventor: Karen Annette Duggan
  • VIP fragments and methods of use
    Patent number: 9340583
    Abstract: The invention relates to composition comprising a pharmaceutically effective amount of one or more functional vasoactive intestinal peptide (VIP) fragments, and the use of those compositions in the treatment of fibrosis, hypertension and other disorder.
    Type: Grant
    Filed: November 17, 2014
    Date of Patent: May 17, 2016
    Assignee: Vectus Biosystems Limited
    Inventor: Karen Annette Duggan
  • VIP FRAGMENTS AND METHODS OF USE
    Publication number: 20150065424
    Abstract: The invention relates to composition comprising a pharmaceutically effective amount of one or more functional vasoactive intestinal peptide (VIP) fragments, and the use of those compositions in the treatment of fibrosis, hypertension and other disorder.
    Type: Application
    Filed: November 17, 2014
    Publication date: March 5, 2015
    Applicant: VECTUS BIOSYSTEMS LIMITED
    Inventor: Karen Annette Duggan
  • VIP fragments and methods of use
    Patent number: 8916523
    Abstract: The invention relates to composition comprising a pharmaceutically effective amount of one or more functional vasoactive intestinal peptide (VIP) fragments, and the use of those compositions in the treatment of fibrosis, hypertension and other disorder.
    Type: Grant
    Filed: May 28, 2013
    Date of Patent: December 23, 2014
    Assignee: Vectus Biosystems Limited
    Inventor: Karen Annette Duggan
  • VIP FRAGMENTS AND METHODS OF USE
    Publication number: 20130244934
    Abstract: The invention relates to composition comprising a pharmaceutically effective amount of one or more functional vasoactive intestinal peptide (VIP) fragments, and the use of those compositions in the treatment of fibrosis, hypertension and other disorder.
    Type: Application
    Filed: May 28, 2013
    Publication date: September 19, 2013
    Applicant: Vectus Biosystems Limited
    Inventor: Karen Annette Duggan